Response to: "Is sclerostin a true mediator of diabetic nephropathy, or just a surrogate of altered bone metabolism?"

Saved in:
Bibliographic Details
Title: Response to: "Is sclerostin a true mediator of diabetic nephropathy, or just a surrogate of altered bone metabolism?"
Authors: Sallam DE; Department of Pediatrics and Pediatric Nephrology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. dinaebrahim2008@med.asu.edu.eg., Elhenawy YIM; Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Ahmed AMA; Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Taha SIA; Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Elsayed EM; Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2025 Oct; Vol. 40 (10), pp. 3329-3330. Date of Electronic Publication: 2025 Aug 02.
Publication Type: Letter
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-198X (Electronic) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1432-198X
DOI:10.1007/s00467-025-06925-9